Abstract
Objective
To evaluate and compare MRI-based ovarian morphology in groups of women with polycystic ovary syndrome (PCOS) and controls.
Methods
All PCOS cases (n = 44) had oligo-amenorrhoea and hyperandrogenism irrespective of ovarian morphology, and fulfilled NIH/Rotterdam diagnostic criteria for PCOS. All control women (n = 40) had normal menses and normoandrogenaemia. All subjects were of white British/Irish origin and pre-menopausal. Group comparisons were based on independent-sample t tests. Polycystic ovarian morphology was defined by at least 12 follicles 2–9 mm in diameter and/or an ovarian volume greater than 10 cm3.
Results
Ovarian morphology differed significantly in PCOS cases and controls (follicle number geometric mean [SD range] 18.6 [9.9, 35.0] vs 6.6 [3.1, 14.2], unadjusted P = 1.3 × 10−16; calculated ovarian volume 8.8 cm3 [5.0, 15.5] vs 5.1 cm3 [2.5, 10.3], unadjusted P = 3.0 × 10–7; peripheral follicle location in 55% vs 18% of ovaries, P = 7.9 × 10–6; visible central ovarian stroma in 61% vs 24% of ovaries, P = 2.3 × 10–5). Follicle number and calculated ovarian volume were not concordant with clinical/biochemical assignment of PCOS/control status in 36 (23%) and 52 (34%) of ovaries, respectively.
Conclusion
Ovarian morphology overlaps in PCOS cases and controls, emphasising the importance of considering clinical/biochemical presentation together with imaging ovarian morphology in the diagnosis of PCOS.
Similar content being viewed by others
References
Barber TM, McCarthy MI, Wass JA, Franks S (2006) Obesity and polycystic ovary syndrome. Clin Endocrinol (Oxf) 65:137–145
Zawadzki J, Dunaif A (1992) Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif AGJ, Haseltine FP, Merriam GR (eds) Polycystic ovary syndrome. Blackwell Scientific, Boston, pp 377–384
The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19:41–47
Balen AH, Laven JS, Tan SL, Dewailly D (2003) Ultrasound assessment of the polycystic ovary: international consensus definitions. Hum Reprod Update 9:505–514
Imaoka I, Wada A, Matsuo M, Yoshida M, Kitagaki H, Sugimura K (2003) MR imaging of disorders associated with female infertility: use in diagnosis, treatment, and management. Radiographics 23:1401–1421
Mitchell DG, Gefter WB, Spritzer CE, Blasco L, Nulson J, Livolsi V, Axel L, Arger PH, Kressel HY (1986) Polycystic ovaries: MR imaging. Radiology 160:425–429
Yoo RY, Sirlin CB, Gottschalk M, Chang RJ (2005) Ovarian imaging by magnetic resonance in obese adolescent girls with polycystic ovary syndrome: a pilot study. Fertil Steril 84:985–995
Faure N, Prat X, Bastide A, Lemay A (1989) Assessment of ovaries by magnetic resonance imaging in patients presenting with polycystic ovarian syndrome. Hum Reprod 4:468–472
Polson DW, Adams J, Wadsworth J, Franks S (1988) Polycystic ovaries—a common finding in normal women. Lancet 1:870–872
The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81:19–25
Adams J, Polson DW, Franks S (1986) Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. Br Med J (Clin Res Ed) 293:355–359
Ayida G, Chamberlain P, Barlow D, Koninckx P, Golding S, Kennedy S (1997) Is routine diagnostic laparoscopy for infertility still justified? A pilot study assessing the use of hysterosalpingo-contrast sonography and magnetic resonance imaging. Hum Reprod 12:1436–1439
Adams JM, Taylor AE, Crowley WF Jr, Hall JE (2004) Polycystic ovarian morphology with regular ovulatory cycles: insights into the pathophysiology of polycystic ovarian syndrome. J Clin Endocrinol Metab 89:4343–4350
Franks S (1989) Polycystic ovary syndrome: a changing perspective. Clin Endocrinol (Oxf) 31:87–120
Swanson M, Sauerbrei EE, Cooperberg PL (1981) Medical implications of ultrasonically detected polycystic ovaries. J Clin Ultrasound 9:219–222
Hauth EA, Umutlu L, Libera H, Kimmig R, Forsting M (2009) Magnetic resonance imaging of the pelvis in patients with polycystic ovary syndrome. Rofo 181:543–548
Lam PM, Raine-Fenning N (2006) The role of three-dimensional ultrasonography in polycystic ovary syndrome. Hum Reprod 21:2209–2215
Lam PM, Johnson IR, Raine-Fenning NJ (2007) Three-dimensional ultrasound features of the polycystic ovary and the effect of different phenotypic expressions on these parameters. Hum Reprod 22:3116–3123
Hahn S, Bering van Halteren W, Roesler S, Schmidt M, Kimmig R, Tan S, Mann K, Janssen OE (2006) The combination of increased ovarian volume and follicle number is associated with more severe hyperandrogenism in German women with polycystic ovary syndrome. Exp Clin Endocrinol Diabetes 114:175–181
Acknowledgements
We acknowledge the patients and nurses who contributed to the ascertainment of the various clinical samples used in this study. Research Fellowships were awarded by NovoNordisk (to TMB) and NIHR (to MG). We acknowledge the Fetal Medicine Unit at the John Radcliffe Hospital, Oxford for use of imaging facilities.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Barber, T.M., Alvey, C., Greenslade, T. et al. Patterns of ovarian morphology in polycystic ovary syndrome: a study utilising magnetic resonance imaging. Eur Radiol 20, 1207–1213 (2010). https://doi.org/10.1007/s00330-009-1643-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00330-009-1643-8